generated: '2026-08-26'
method: searched
source: https://qnovia.com/
plan_count: 0
plans: []
note: >-
  Qnovia publishes no pricing, plans, or commercial terms of any kind. It is a clinical-stage
  pharmaceutical and drug-device company; its lead asset, the RespiRx Nicotine Inhaler (QN-01), is an
  investigational prescription product in Phase 1 and is not for sale. The corporate site's route
  table contains no /pricing, /plans, or /buy page, and there is no API, so there is no API pricing
  surface either. This is a genuine absence rather than an enterprise "contact sales" gate.